Oropharyngeal cancer as a driver of racial outcome disparities in squamous cell carcinoma of the head and neck: 10-year experience at the University of Maryland Greenebaum Cancer Center

被引:46
|
作者
Zandberg, Dan P. [1 ,2 ]
Liu, Sandy [3 ]
Goloubeva, Olga [2 ]
Ord, Robert [2 ,4 ]
Strome, Scott E. [5 ]
Suntharalingam, Mohan [6 ]
Taylor, Rodney [5 ]
Morales, Robert E. [7 ]
Wolf, Jeffrey S. [5 ]
Zimrin, Ann [1 ,2 ]
Lubek, Joshua E. [2 ,4 ]
Schumaker, Lisa M. [2 ]
Cullen, Kevin J. [1 ,2 ]
机构
[1] Univ Maryland, Sch Med, Dept Med, Div Med Oncol, Baltimore, MD 21201 USA
[2] Univ Maryland, Marlene & Stewart Greenebaum Canc Ctr, Baltimore, MD 21201 USA
[3] Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21201 USA
[4] Univ Maryland, Sch Med, Dept Oral & Maxillofacial Surg, Baltimore, MD 21201 USA
[5] Univ Maryland, Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Baltimore, MD 21201 USA
[6] Univ Maryland, Sch Med, Dept Radiat Oncol, Baltimore, MD 21201 USA
[7] Univ Maryland, Sch Med, Dept Radiol, Baltimore, MD 21201 USA
关键词
race; head and neck squamous cell carcinoma (HNSCC); oropharyngeal; survival; disparity; HUMAN-PAPILLOMAVIRUS; TREATMENT PATTERNS; AFRICAN-AMERICANS; PHARYNGEAL CANCER; LARYNGEAL-CANCER; ORAL-CANCER; SURVIVAL; STAGE; RACE; STATISTICS;
D O I
10.1002/hed.23933
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Background. Racial outcome disparities have been observed in head and neck squamous cell carcinoma (HNSCC) with diminished survival for black patients compared with white patients. Methods. We retrospectively analyzed 1318 patients with primary HNSCC treated at the University of Maryland Greenebaum Cancer Center (UMGCC) from 2000 to 2010. Results. Of all the patients, 65.9% were white, 30.7% were black, and 3.3% were of other races. Black patients were less likely to present with oral cavity cancer, and more likely to present with laryngeal or hypopharyngeal cancers. White patients were more likely to have early stage disease, especially in the oral cavity. Black race was independently associated with worse overall survival (OS) in the entire cohort. Black patients had a significantly worse OS among oral cavity and oropharyngeal cancers, with the largest disparity in oropharyngeal cancer. However, in multivariate analysis, race was only still significant in oropharyngeal cancer. Conclusion. We observed differences by race in distribution of disease site, stage, and OS. Survival disparity in the entire cohort was driven mostly by differences among oropharyngeal cancer. (C) 2015 Wiley Periodicals, Inc.
引用
收藏
页码:564 / 572
页数:9
相关论文
共 50 条
  • [21] Five-year outcome of patients with squamous cell carcinoma of the breast: the University of Texas M. D. Anderson Cancer Center experience.
    Hennessy, BT
    Krishnamurthy, S
    Valero, V
    Hortobagyi, G
    BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S63 - S63
  • [22] Analysis of primary oral and oropharyngeal squamous cell carcinoma in inhabitants of Beijing, China—a 10-year continuous single-center study
    Xue-Xiao Bai
    Jie Zhang
    Li Wei
    BMC Oral Health, 20
  • [23] The mouse oral carcinoma (MOC) model: A 10-year retrospective on model development and head and neck cancer investigations
    Kono, Michihisa
    Saito, Shin
    Egloff, Ann Marie
    Allen, Clint T.
    Uppaluri, Ravindra
    ORAL ONCOLOGY, 2022, 132
  • [24] Features predicting metastasis in cutaneous squamous cell carcinoma of the head and neck: a 10-year review of cases in the South East of England
    Di Palma, S.
    Mathew, R.
    Walker, D.
    Gutierrez, T.
    Pitkin, L.
    Whitaker, S.
    Sudderick, R.
    Dandford, M.
    VIRCHOWS ARCHIV, 2011, 459 : S109 - S110
  • [25] Correction to: Investigating Trends of Incidence Rates of Esophageal Cancer Divided by Squamous Cell Carcinoma and Adenocarcinoma in Southern Iran: a 10-Year Experience
    Mahnaz Hosseini-Bensenjan
    Hossein Molavi Vardanjani
    Sezaneh Haghpanah
    Zahra Khosravizadegan
    Kamran Bagheri-Lankarani
    Journal of Gastrointestinal Cancer, 2022, 53 : 235 - 235
  • [26] Circulating Invariant Natural Killer T-Cell Numbers Predict Outcome in Head and Neck Squamous Cell Carcinoma: Updated Analysis With 10-Year Follow-Up
    Schneiders, Famke L.
    de Bruin, Renee C. G.
    van den Eertwegh, Alfons J. M.
    Scheper, Rik J.
    Leemans, C. Rene
    Brakenhoff, Ruud H.
    Langendijk, Johannes A.
    Verheul, Henk M. W.
    de Gruijl, Tanja D.
    Molling, Johan W.
    van der Vliet, Hans J.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05) : 567 - 570
  • [27] Concomitant chemoradiation using weekly cisplatin for advanced squamous cell carcinoma of head and neck: Experience from a tertiary cancer center in India.
    Sharma, A.
    Mohanti, B. K.
    Thakar, A.
    Chaudhary, S. P.
    Bhasker, S.
    Bahadur, S.
    Sharma, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [28] Analysis of primary oral and oropharyngeal squamous cell carcinoma in inhabitants of Beijing, China-a 10-year continuous single-center study
    Bai, Xue-Xiao
    Zhang, Jie
    Wei, Li
    BMC ORAL HEALTH, 2020, 20 (01)
  • [29] Real-World Experience of Immunotherapy from India in Recurrent Squamous Cell Carcinoma of Head and Neck Cancer
    Abbas, Waseem
    Gupta, Saurabh
    Goel, Vineeta
    Rao, Ranga R.
    Pankaj, Promila
    Tripathi, Devashish
    Patil, Pratik P.
    Popli, Swati
    SOUTH ASIAN JOURNAL OF CANCER, 2021, 10 (02) : 72 - 75
  • [30] The association of treatment delay and prognosis in head and neck squamous cell carcinoma (HNSCC) patients in a Dutch comprehensive cancer center
    van Harten, Michel C.
    de Ridder, Mischa
    Hamming-Vrieze, Olga
    Smeele, Ludi E.
    Balm, Alfons J. M.
    van den Brekel, Michiel W. M.
    ORAL ONCOLOGY, 2014, 50 (04) : 282 - 290